Moderate benefit: At least 30% reduction in pain, or PGIC much or very much improved · adults with chronic neuropathic pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Moderate benefit: At least 30% reduction in pain, or PGIC much or very much improved · adults with fibromyalgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
At least 30% reduction in pain or equivalent (moderate) · adults with fibromyalgia
1 finding from 1 review
Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
Tramadol showed no clear difference in number of patients with moderate to severe pain (PACU) compared with pethidine (low certainty).
1 finding from 1 review
Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
1 finding from 1 review
Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
1 finding from 1 review
Intervention not reported
At least 30% reduction in pain or equivalent (moderate) · adults with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
"Moderate" benefit At least 30% reduction in pain · adults with neuropathic pain (Trigeminal neuralgia, painful diabetic neuropathy, chronic post stroke pain)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
"Moderate" benefit At least 30% reduction in pain · Adults with cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of patients with moderate/severe pain (1 hour postoperatively) · children undergoing surgery
Nalbuphine may leads to lower number of patients with moderate/severe pain (1 hour postoperatively) compared with placebo (low certainty).
2 findings from 1 review
Number of patients with moderate/severe pain (1 hour postoperatively) · children undergoing surgery
1 finding from 1 review
Number of patients with moderate/severe pain (1 hour postoperatively) · children undergoing surgery
1 finding from 1 review
Number of patients with moderate/severe pain (1 hour postoperatively) · children undergoing surgery
Nalbuphine showed no clear difference in number of patients with moderate/severe pain (1 hour postoperatively) compared with morphine (low certainty).
2 findings from 1 review
Intervention not reported
"Moderate" benefit At least 30% reduction in pain · neuropathic pain (5 studies in painful diabetic neuropathy and polyneuropathy)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Patient Global Impression of Change much or very much improved (patient global evaluation of pain relief complete, good or moderate) · neuropathic pain (6 studies in central neuropathic pain due to multiple sclerosis, spinal cord injury, polyneuropathy, central post‐stroke…
1 finding from 1 review
Intervention not reported
"Moderate" benefit At least 30% reduction in pain · adults with peripheral neuropathic pain conditions
1 finding from 1 review
Intervention not reported
Patient Global Impression of Change much or very much improved (PGPR "complete", "a lot", or "moderate") · adults with neuropathic pain (3 studies in painful diabetic neuropathy and postherpetic neuralgia)
1 finding from 1 review
Interventions (corticosteroids included in all regimens)a · adult cancer patients at risk for CINV caused by moderately emetogenic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found